BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28322836)

  • 1. Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells.
    Heo SK; Noh EK; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2017 Jun; 804():52-56. PubMed ID: 28322836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.
    Heo SK; Noh EK; Kim JY; Jeong YK; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Sci Rep; 2017 Nov; 7(1):15278. PubMed ID: 29127384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
    Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.
    Heo SK; Noh EK; Yoon DJ; Jo JC; Choi Y; Koh S; Baek JH; Park JH; Min YJ; Kim H
    PLoS One; 2015; 10(6):e0129853. PubMed ID: 26065685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression.
    Heo SK; Noh EK; Jeong YK; Ju LJ; Sung JY; Yu HM; Cheon J; Koh S; Min YJ; Choi Y; Jo JC
    Tumour Biol; 2019 May; 41(5):1010428319848612. PubMed ID: 31074363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
    Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Application of Radotinib for the Treatment of Solid Tumors via Natural Killer Cell Activation.
    Kim KE; Park S; Cheon S; Kim DY; Cho DJ; Park JM; Hur DY; Park HJ; Cho D
    J Immunol Res; 2018; 2018():9580561. PubMed ID: 30687767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
    Gao XN; Lin J; Gao L; Li YH; Wang LL; Yu L
    Leuk Res; 2011 Sep; 35(9):1226-32. PubMed ID: 21724256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway.
    Heo SK; Noh EK; Kim JY; Yu HM; Sung JY; Ju LJ; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh S; Min YJ; Choi Y; Jo JC
    Sci Rep; 2021 Jun; 11(1):13198. PubMed ID: 34168229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
    Do YR; Kwak JY; Kim JA; Kim HJ; Chung JS; Shin HJ; Kim SH; Bunworasate U; Choi CW; Zang DY; Oh SJ; Jootar S; Reksodiputro AH; Lee WS; Mun YC; Kong JH; Caguioa PB; Kim H; Park J; Kim DW
    Br J Haematol; 2020 Apr; 189(2):303-312. PubMed ID: 32012231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin Down-Regulates c-KIT Gene Expression and Exerts Antileukemic Effects on Human Acute Myeloid Leukemia Cells.
    Chen PY; Chen YT; Gao WY; Wu MJ; Yen JH
    J Agric Food Chem; 2018 Dec; 66(51):13423-13434. PubMed ID: 30507186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.
    Hirano T; Yoshikawa R; Harada H; Harada Y; Ishida A; Yamazaki T
    Mol Cancer; 2015 Apr; 14():90. PubMed ID: 25928165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
    Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
    PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
    Woźniak J; Kopeć-Szlezak J
    Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Yu G; Yin C; Jiang L; Zheng Z; Wang Z; Wang C; Zhou H; Jiang X; Liu Q; Meng F
    Oncol Rep; 2016 Sep; 36(3):1626-32. PubMed ID: 27460334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
    Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
    Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF/C-KIT signaling modulates tryptase expression in acute myeloid leukemia cells.
    Jin J; Li Y; Wang Y; Wang P; Wang Y
    Int J Hematol; 2014 Jun; 99(6):750-7. PubMed ID: 24806698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.